Bridging Technology and Therapeutics in ODTs
The rise in ODTs has transformed expectations in oral drug delivery, particularly for chronic care. Superdisintegrants have become a key technology enabling faster therapeutic onset and better patient experiences. What’s notable is how excipient technology is no longer just a formulation afterthought—it’s a strategic advantage. The integration of advanced superdisintegrants into formulations is helping pharma companies improve product performance and differentiation, especially in competitive generics markets.
To Get a PDF Sample Copy of the Report, visit @ https://www.emergenresearch.com/request-sample/4308
1 View